Invention Grant
US08946219B2 Combination therapy with a compound acting as a platelet ADP receptor inhibitor
有权
用作为血小板ADP受体抑制剂的化合物组合治疗
- Patent Title: Combination therapy with a compound acting as a platelet ADP receptor inhibitor
- Patent Title (中): 用作为血小板ADP受体抑制剂的化合物组合治疗
-
Application No.: US12908837Application Date: 2010-10-20
-
Publication No.: US08946219B2Publication Date: 2015-02-03
- Inventor: Pamela B. Conley , Patrick Andre , Uma Sinha
- Applicant: Pamela B. Conley , Patrick Andre , Uma Sinha
- Applicant Address: US CA South San Francisco
- Assignee: Portola Pharmaceuticals, Inc.
- Current Assignee: Portola Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Sheppard Mullin Richter & Hampton LLP
- Main IPC: A01N43/58
- IPC: A01N43/58 ; A61K31/50 ; A01N43/54 ; C07D239/42 ; C07D401/04 ; C07D471/04 ; C07D471/22 ; A61K31/505 ; A01N43/06 ; A61K31/38 ; A01N43/02 ; A01N43/12 ; A61K31/422 ; A61K31/235 ; A61K31/435 ; A61K31/517 ; A61K38/48 ; A61K45/06 ; A61K31/4545
Abstract:
The present invention is directed to pharmaceutical compositions and methods of using combination therapies containing [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea, or a pharmaceutically acceptable salt thereof, for the treatment of thrombosis diseases.
Public/Granted literature
- US20110033459A1 COMBINATION THERAPY WITH A COMPOUND ACTING AS A PLATELET ADP RECEPTOR INHIBITOR Public/Granted day:2011-02-10
Information query
IPC分类:
